CoChat

Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases

Open access
Pablos, Jose L, Abasolo, Lydia, Alvaro-Gracia, Jose M, Blanco, Francisco J, Blanco, Ricardo, Castrejón, Isabel, Fernandez-Fernandez, David, Fernandez-Gutierrez, Benjamín, Galindo-Izquierdo, María, Gonzalez-Gay, Miguel A, Manrique-Arija, Sara, Mena Vázquez, Natalia, Mera Varela, Antonio, Retuerto, Miriam, Seijas-Lopez, Alvaro · 2020 · Annals of the Rheumatic Diseases
Cited by 156

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background The susceptibility of patients with rheumatic diseases and the risks or benefits of immunosuppressive therapies for COVID-19 are unknown. Methods We performed a retrospective study with patients under follow-up in rheumatology departments from seven hospitals in Spain. We matched updated databases of rheumatology patients with severe acute respiratory syndrome coronavirus 2-positive PCR tests performed in the hospital to the same reference populations. Rates of PCR+ confirmed COVID-19 were compared among groups. Results Patients with chronic inflammatory diseases had 1.32-fold higher prevalence of hospital PCR+ COVID-19 than the reference population (0.76% vs 0.58%). Patients with systemic autoimmune or immune-mediated disease (AI/IMID) showed a significant increase, whereas patients with inflammatory arthritis (IA) or systemic lupus erythematosus did not. COVID-19 cases in some but not all diagnostic groups had older ages than cases in the reference population. Patients with IA on targeted-synthetic or biological disease-modifying antirheumatic drugs (DMARDs), but not those on conventional-synthetic DMARDs, had a greater prevalence despite a similar age distribution. Conclusion Patients with AI/IMID show a variable risk of hospital-diagnosed COVID-19. Interplay of ageing, therapies and disease-specific factors seem to contribute. These data provide a basis to improve preventive recommendations to rheumatic patients and to analyse the specific factors involved in COVID-19 susceptibility.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2020-217763

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 156

Metadata

Authors
Pablos, J. L., Abasolo, L., Alvaro-Gracia, J. M., Blanco, F. J., Blanco, R., Castrejón, I., Fernandez-Fernandez, D., Fernandez-Gutierrez, B., Galindo-Izquierdo, M., Gonzalez-Gay, M. A., Manrique-Arija, S., Mena Vázquez, N., Mera Varela, A., Retuerto, M., & Seijas-Lopez, A.
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2020-09
Volume
79
Issue
9
Pages
1170-1173
ISSN
0003-4967 (ISSN-L)
OpenAlex
W3035490593
Cited by
156
References
2
FWCI
4.32
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases. https://app.cochat.ai/papers/10.1136/annrheumdis-2020-217763
The paper
Pablos, J. L., Abasolo, L., Alvaro-Gracia, J. M., Blanco, F. J., Blanco, R., Castrejón, I., Fernandez-Fernandez, D., Fernandez-Gutierrez, B., Galindo-Izquierdo, M., Gonzalez-Gay, M. A., Manrique-Arija, S., Mena Vázquez, N., Mera Varela, A., Retuerto, M., & Seijas-Lopez, A. (2020). Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-217763

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.